Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
August 31, 2004
Primary Completion Date
May 31, 2006
Conditions
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
DRUG
mycophenolate mofetil
DRUG
tacrolimus
Trial Locations (1)
98109-1024
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Fred Hutchinson Cancer Center
OTHER
NCT00096096 - Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation | Biotech Hunter | Biotech Hunter